
Sudarshan Pharma Industries Ltd Sees Bullish Momentum Shift Amid Strong Technical Signals
2026-05-21 08:04:28Sudarshan Pharma Industries Ltd has demonstrated a marked shift in price momentum, supported by a suite of bullish technical indicators. The micro-cap specialty chemicals company’s shares surged 5.00% on 21 May 2026, closing at ₹32.57, signalling renewed investor confidence and an upgrade in its technical outlook from mildly bullish to bullish.
Read MoreSudarshan Pharma Industries Ltd Falls 2.23%: 4 Key Factors Driving the Weekly Shift
2026-05-09 11:01:09Key Events This Week 4 May: Technical momentum shifts to mildly bullish amid sector rally 5 May: Bullish momentum confirmed with technical upgrades and price rise to Rs.31.00 6 May: MarketsMOJO upgrades rating to Buy following strong financial performance 7 May: Technical momentum moderates to mildly bullish amid mixed signals 8 May: Week closes at Rs.30.30, down 2.23% for the week versus Sensex +1.25% <div cla...
Read More
Sudarshan Pharma Industries Ltd Forms Golden Cross Amid Mixed Technical Signals
2026-04-30 18:00:24The 50-day moving average has crossed above the 200-day moving average for Sudarshan Pharma Industries Ltd, signalling a golden cross on 30 Apr 2026. Yet, the broader technical picture is nuanced, with monthly indicators showing mild bearishness and the stock’s recent price action reflecting a more complex momentum story.
Read MoreWhen is the next results date for Sudarshan Pharma Industries Ltd?
2026-04-28 23:16:38The next results date for Sudarshan Pharma Industries Ltd is scheduled for April 30, 2026....
Read More
Sudarshan Pharma Industries Ltd is Rated Sell
2026-04-23 10:10:04Sudarshan Pharma Industries Ltd is rated Sell by MarketsMOJO, with this rating last updated on 19 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 23 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Sudarshan Pharma Industries Ltd is Rated Sell
2026-04-12 10:10:02Sudarshan Pharma Industries Ltd is rated Sell by MarketsMOJO, with this rating last updated on 19 Oct 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 12 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.
Read More
Sudarshan Pharma Industries Ltd: Technical Momentum Shifts Amid Mixed Market Signals
2026-04-08 08:04:04Sudarshan Pharma Industries Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend. Despite a strong day gain of 4.69%, the stock’s technical indicators present a mixed picture, reflecting both cautious optimism and lingering bearish undertones. This analysis delves into the recent price action, key technical signals, and comparative performance against the broader market.
Read More
Sudarshan Pharma Industries Ltd is Rated Sell
2026-04-01 10:10:03Sudarshan Pharma Industries Ltd is rated Sell by MarketsMOJO, with this rating last updated on 19 Oct 2025. However, all fundamentals, returns, and financial metrics discussed here reflect the stock’s current position as of 01 April 2026, providing investors with the latest comprehensive analysis.
Read More
Sudarshan Pharma Industries Ltd is Rated Sell
2026-03-21 10:10:03Sudarshan Pharma Industries Ltd is rated Sell by MarketsMOJO, with this rating last updated on 19 Oct 2025. However, all fundamentals, returns, and financial metrics discussed here reflect the stock’s current position as of 21 March 2026, providing investors with an up-to-date analysis of the company’s standing.
Read MoreBoard Meeting Intimation for Meeting Of The Board Of Directors Of The Company Scheduled To Be Held On Thursday 18Th June 2026
15-Jun-2026 | Source : BSESudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/06/2026 inter alia to consider and approve proposal for raising of funds by way of issue of one or more instruments through private placement / preferential issue or such method or combination thereof subject to statutory / regulatory approvals as may be necessary.
Announcement under Regulation 30 (LODR)-Allotment
12-Jun-2026 | Source : BSEPursuant to Regulation 30 of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 the Warrants Committee of the Board of Directors of the Company have at their meeting held today 12/June/2026 considered and approved the allotment of 9000000 equity shares of Re.1/- each consequent upon conversion of 900000 warrants to persons belonging to Promoter Category on a preferential basis as per details given in Annexure I. The disclosures required under Regulation 30 read with Schedule III of SEBI Listing Regulations read with SEBI Master Circular dated 11/Nov/2024 are provided in Annexure II.
Meeting Of Warrants Committee Of The Company Scheduled On Thursday 11/June/2026 Now Postponed To Friday 12/June/2026
11-Jun-2026 | Source : BSEWe wish to inform you that the meeting of the Warrants Committee of the Company originally scheduled on 11/June/2026 has been postponed and will now be held on Friday 12/June/2026.
Corporate Actions
(18 Jun 2026)
Sudarshan Pharma Industries Ltd has declared 3% dividend, ex-date: 25 Aug 23
Sudarshan Pharma Industries Ltd has announced 1:10 stock split, ex-date: 22 Nov 24
No Bonus history available
No Rights history available